Biologic Specimen and Data Repository Information Coordinating Center
Home > Proprietary Studies > BMT CTN 0201

Resources Available

Specimens Only

Materials Available

Plasma
Serum

Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Comparing Peripheral Blood Stem Cell Transplantation Versus Bone Marrow Transplantation in Individuals With Hematologic Cancers (BMT CTN 0201)

Website: https://web.emmes.com/study/bmt2
Parent Study Contact: Alan Howard, ahoward@nmdp.org
Study Type: Clinical Trial
Prepared on September 14, 2010
Consent: Restricted Consent
Consent Restrictions: For protocol use only
Commercial Use Restrictions: No
Collection Type: Proprietary Study - See bottom of this webpage for request information

Objectives

The study is a Phase III, randomized, open label, multicenter, prospective, comparative trial of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells (PBSC) versus marrow from unrelated donors for transplantation in patients with hematologic malignancies.


Interested parties should review the Proprietary Study application process before they begin. Requests for Proprietary Studies must be approved by the Parent Study before they can be processed by BioLINCC. Contact information for the Parent Study is provided at the top of this webpage. Upon Parent Study approval, click the Request button to start a request through BioLINCC.